Chan Sue L F, Monks Lara K, Gao Hongwei, Deaville Pamela, Morgan Noel G
Institute of Cell Signalling, University of Nottingham, Queen's Medical Centre, Nottingham NG7 2UH, UK.
Br J Pharmacol. 2002 May;136(1):31-6. doi: 10.1038/sj.bjp.0704680.
Efaroxan induces membrane depolarization by interaction with the pore forming subunit of the ATP-sensitive potassium channel, Kir6.2. However, this effect is not responsible for its full secretory activity. In this study we have used an anti-idiotypic approach to generate antibodies that recognize additional proteins that may be regulated by efaroxan in pancreatic beta-cells. Using these antisera in an expression cloning strategy we have identified a monomeric GTP-binding protein, Rhes, as a potential target for regulation by imidazoline ligands. Rhes is shown to be expressed in beta-cells and its expression is regulated by efaroxan under conditions when a structurally related molecule, KU14R, is ineffective. The results reveal that beta-cells express Rhes and suggest that changes in the expression of this molecule may regulate the sensitivity of beta-cells to imidazoline secretagogues.
依法拉赞通过与ATP敏感性钾通道的孔形成亚基Kir6.2相互作用诱导膜去极化。然而,这种效应并非其全部分泌活性的原因。在本研究中,我们采用抗独特型方法生成抗体,以识别胰腺β细胞中可能受依法拉赞调节的其他蛋白质。在表达克隆策略中使用这些抗血清,我们鉴定出一种单体GTP结合蛋白Rhes,作为咪唑啉配体调节的潜在靶点。结果表明Rhes在β细胞中表达,并且在结构相关分子KU14R无效的条件下,其表达受依法拉赞调节。这些结果揭示β细胞表达Rhes,并表明该分子表达的变化可能调节β细胞对咪唑啉促分泌剂的敏感性。